We analysed and scored expression levels of TGF-β, Smad2, and Smad4 proteins in 122 FFPE specimens by IHC staining and investigated the association between protein expression and the clinicopathologic characteristics of CRC patients. This evidence concerns the gene SMAD4 and colorectal carcinoma.